BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26412469)

  • 21. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation.
    Bruschi G; de Marco F; Botta L; Cannata A; Oreglia J; Colombo P; Barosi A; Colombo T; Nonini S; Paino R; Klugmann S; Martinelli L
    Ann Thorac Surg; 2012 Aug; 94(2):497-503. PubMed ID: 22633495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes.
    Kempfert J; Treede H; Rastan AJ; Schönburg M; Thielmann M; Sorg S; Mohr FW; Walther T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):52-6; discussion 57. PubMed ID: 22491663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transapical aortic valve implantation using a Symetis Acurate self-expandable bioprosthesis: initial outcomes of 10 patients.
    Misterski M; Puślecki M; Grygier M; Olasińska-Wiśniewska A; Lesiak M; Araszkiewicz A; Perek B; Choręziak A; Lindner J; Komosa A; Buczkowski P; Ligowski M; Katarzyński S; Jemielity M
    Wideochir Inne Tech Maloinwazyjne; 2017 Jun; 12(2):172-177. PubMed ID: 28694904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter ACURATE-TA Aortic Valve Implantation in a Patient With a Previous Mechanical Mitral Valve.
    Bagur R; Kiaii B; Teefy PJ; Diamantouros P; Harle C; Goela A; Chan I; Chu MW
    Ann Thorac Surg; 2015 Nov; 100(5):e115-7. PubMed ID: 26522576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease].
    Rescigno G; Fratesi MG; Aratari C; Moretti S; Capestro F; Serenelli M; Piangerelli L; Delca A; Perna GP; Capucci A; Di Eusanio M
    G Ital Cardiol (Rome); 2017 Oct; 18(10):727-733. PubMed ID: 29105687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfemoral transcatheter ACURATE-neo™ aortic valve replacement in a patient with a previous mechanical mitral valve.
    Bagur R; Pestrichella V; Montesanti R; Alemanni R; Cassese M
    J Card Surg; 2017 Jun; 32(6):358-360. PubMed ID: 28544015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC; Thourani VH; Kodali SK; Makkar RR; Szeto WY; Anwaruddin S; Desai N; Lim S; Malaisrie SC; Kereiakes DJ; Ramee S; Greason KL; Kapadia S; Babaliaros V; Hahn RT; Pibarot P; Weissman NJ; Leipsic J; Whisenant BK; Webb JG; Mack MJ; Leon MB;
    Circulation; 2016 Jul; 134(2):130-40. PubMed ID: 27400898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfemoral aortic valve implantation using a self-expanding transcatheter heart valve without pre-dilation.
    Kim WK; Liebetrau C; Renker M; Rolf A; Van Linden A; Arsalan M; Husser O; Möllmann H; Hamm C; Walther T
    Int J Cardiol; 2017 Sep; 243():156-160. PubMed ID: 28579166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients.
    Wilbring M; Sill B; Tugtekin SM; Alexiou K; Simonis G; Matschke K; Kappert U
    Ann Thorac Surg; 2012 Mar; 93(3):734-41. PubMed ID: 22304904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis.
    Kooistra NH; Intan-Goey VMP; Ziviello F; Leenders GE; Kraaijeveld AO; Doevendans PA; Van Mieghem NM; Voskuil M; Stella PR
    Catheter Cardiovasc Interv; 2021 Mar; 97(4):E597-E606. PubMed ID: 32886869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symetis ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve.
    Schäfer U; Conradi L; Diemert P; Deuschl F; Schofer N; Seiffert M; Lubos E; Schirmer J; Reichenspurner H; Blankenberg S; Treede H
    Minerva Cardioangiol; 2015 Oct; 63(5):359-69. PubMed ID: 26198875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcatheter aortic valve implantation using a direct aortic approach: a single-centre Heart Team experience.
    Amrane H; Porta F; van Boven AJ; Boonstra PW; Hofma SH; Head SJ; Kappetein AP
    Interact Cardiovasc Thorac Surg; 2014 Nov; 19(5):777-81. PubMed ID: 25074233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.
    Toutouzas K; Latsios G; Stathogiannis K; Drakopoulou M; Synetos A; Sanidas E; Mastrokostopoulos A; Trantalis G; Kaitozis O; Lazaros G; Yuecel S; Gerckens U; Grube E; Tousoulis D
    Int J Cardiol; 2016 Jan; 202():631-5. PubMed ID: 26451789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: feasibility and safety.
    Fiorina C; Maffeo D; Curello S; Lipartiti F; Chizzola G; D'Aloia A; Adamo M; Mastropierro R; Gavazzi E; Ciccarese C; Chiari E; Ettori F
    Cardiovasc Revasc Med; 2014 Jun; 15(4):200-3. PubMed ID: 24746865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.
    Seiffert M; Fujita B; Avanesov M; Lunau C; Schön G; Conradi L; Prashovikj E; Scholtz S; Börgermann J; Scholtz W; Schäfer U; Lund G; Ensminger S; Treede H
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):576-84. PubMed ID: 26160399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midterm outcomes after transcatheter aortic valve implantation.
    Lotfi S; Dohmen G; Götzenich A; Haushofer M; Spillner JW; Autschbach R; Hoffmann R
    Innovations (Phila); 2014; 9(5):343-7; discussion 348. PubMed ID: 25238419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.
    Wenaweser P; Stortecky S; Heg D; Tueller D; Nietlispach F; Falk V; Pedrazzini G; Jeger R; Reuthebuch O; Carrel T; Räber L; Amann FW; Ferrari E; Toggweiler S; Noble S; Roffi M; Gruenenfelder J; Jüni P; Windecker S; Huber C
    EuroIntervention; 2014 Dec; 10(8):982-9. PubMed ID: 24694729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful percutaneous implantation of Symetis ACURATE neo transcatheter aortic bioprosthesis in a patient with existing mechanical mitral valve.
    Ali S; Alsancak Y; Duran M; Bilge M
    Anatol J Cardiol; 2016 Nov; 16(11):E20. PubMed ID: 27872440
    [No Abstract]   [Full Text] [Related]  

  • 39. Valve-in-valve transcatheter aortic valve implantation for failing surgical aortic stentless bioprosthetic valves: A single-center experience.
    Duncan A; Davies S; Di Mario C; Moat N
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):91-8. PubMed ID: 25869089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated small surgical bioprostheses: the Hamburg experience.
    Diemert P; Seiffert M; Frerker C; Thielsen T; Kreidel F; Bader R; Schirmer J; Conradi L; Koschyk D; Schnabel R; Reichenspurner H; Blankenberg S; Kuck KH; Treede H; Schaefer U
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):486-93. PubMed ID: 24753352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.